SV Health Investors Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • SV Health Investors's estimated annual revenue is currently $75M per year.(i)
  • SV Health Investors's estimated revenue per employee is $757,576

Employee Data

  • SV Health Investors has 99 Employees.(i)
  • SV Health Investors grew their employee count by 0% last year.

SV Health Investors's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VPReveal Email/Phone
3
VPReveal Email/Phone
4
chief administrative partneReveal Email/Phone
5
Compliance OfficerReveal Email/Phone
6
ControllerReveal Email/Phone
7
Partner - Finance Director / CROReveal Email/Phone
8
Managing Partner & Chief Operating OfficerReveal Email/Phone
9
Chief Financial Officer and PartnerReveal Email/Phone
10
Director FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$558.4M26930%€3BN/A
Add Company

What Is SV Health Investors?

SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams. SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages four funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $20m in North America and Europe, but will consider innovative investments in other regions. Our team of 28 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.

keywords:N/A

N/A

Total Funding

99

Number of Employees

$75M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SV Health Investors News

2022-04-20 - Financing round-up: Rona Therapeutics, Us2.ai, CDR-Life ...

The second closing includes new investor, SV Health Investors, a transatlantic venture… You must be a HMI Subscriber to view this content. Login...

2022-04-17 - Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena ...

Prilenia Therapeutics: Houman Ashrafian, managing partner at S.V. Health Investors, co-lead of S.V.'s Biotech franchise,...

2022-04-13 - SV Health Investors Joins Prilenia Series B as the Company ...

The second closing includes new investor, SV Health Investors, a leading transatlantic venture capital and growth equity firm, with offices in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M995%N/A
#2
$25.1M9913%N/A
#3
$14.9M9950%N/A
#4
$15.8M9962%N/A
#5
$26.7M99-10%N/A